Efficacy Of Hiatal Closure For GERD

NCT06280664 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-02-02

No results posted yet for this study

Summary

The purpose of this protocol is to study the efficacy of hiatal closure for early GERD disease. The study team hypothesizes that hiatal closure for early GERD disease is an efficacious treatment of GERD.

Conditions

  • Gastro Esophageal Reflux

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Yalini Vigneswaran, MD · University of Chicago

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-02
Primary Completion
2028-10-31
Completion
2028-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06280664 on ClinicalTrials.gov